Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Heart

Retrieve available abstracts of 179 articles:
HTML format

Single Articles

    March 2024
  1. SOORAMPALLY V, Veeraraghavan S, Kidambi BR
    Dyspnoea, dizziness and dysrhythmia in a middle-aged patient.
    Heart. 2024;110:559-614.

  2. ISHIKITA A, McIntosh C, Roche SL, Barron DJ, et al
    Incremental value of machine learning for risk prediction in tetralogy of Fallot.
    Heart. 2024;110:560-568.
    PubMed     Abstract available

  3. VINTER N, Cordsen P, Johnsen SP, Benjamin EJ, et al
    Birth cohort effects on diagnosed atrial fibrillation incidence: nationwide cohort study from 1980 to 2018.
    Heart. 2024 Mar 12:heartjnl-2023-323737. doi: 10.1136/heartjnl-2023-323737.
    PubMed     Abstract available

  4. SAMUEL M, Rienstra M
    Birth cohort effect in atrial fibrillation: a matter of detection?
    Heart. 2024 Mar 12:heartjnl-2024-323950. doi: 10.1136/heartjnl-2024-323950.

    January 2024
  5. VAN HATTUM JC, Daems JJN, Verwijs SM, Wismans LV, et al
    Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports.
    Heart. 2024;110:254-262.
    PubMed     Abstract available

    Determining risk of sudden death: is it all in the T wave?
    Heart. 2024;110:151-153.

  7. HNATKOVA K, Andrsova I, Novotny T, Vanderberk B, et al
    QRS complex and T wave planarity for the efficacy prediction of automatic implantable defibrillators.
    Heart. 2024;110:178-187.
    PubMed     Abstract available

    Inequities in access and use of automated external defibrillators.
    Heart. 2024;110:154-155.

  9. VAN DER VELDEN RMJ, Bonander C, Crijns HJGM, Kemp-Gudmundsdottir K, et al
    Adherence to a handheld device-based atrial fibrillation screening protocol is associated with clinical outcomes.
    Heart. 2024 Jan 5:heartjnl-2023-323522. doi: 10.1136/heartjnl-2023-323522.
    PubMed     Abstract available

    December 2023
  10. JOHANSSON M, Fedorowski A
    Situational vs vasovagal syncope: one but different?
    Heart. 2023;110:3-4.

  11. SATURI G, De Frutos F, Sguazzotti M, Gonzalez-Lopez E, et al
    Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis.
    Heart. 2023;110:40-48.
    PubMed     Abstract available

    November 2023
  12. FREDERIKSEN TC, Christiansen MK, Benjamin EJ, Overvad K, et al
    Interaction of genetic risk and lifestyle on the incidence of atrial fibrillation.
    Heart. 2023 Nov 28:heartjnl-2023-323333. doi: 10.1136/heartjnl-2023-323333.
    PubMed     Abstract available

  13. VAZIR A, Kapelios CJ
    Sleep-disordered breathing and cardiovascular disease: who and why to test and how to intervene?
    Heart. 2023;109:1864-1870.
    PubMed     Abstract available

  14. LAWIN D, Stellbrink C, Stellbrink E, Buck B, et al
    Alcohol septal ablation in patients aged 75 years or older with hypertrophic obstructive cardiomyopathy.
    Heart. 2023;109:1778-1784.
    PubMed     Abstract available

  15. BAROUTIDOU A, Arvanitaki A, Farmakis IT, Patsiou V, et al
    Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis.
    Heart. 2023;109:1741-1750.
    PubMed     Abstract available

  16. OTTO CM
    Heartbeat: atrial fibrillation phenotyping identifies patients at high risk of adverse events.
    Heart. 2023;109:1725-1726.

    October 2023
  17. OTTO CM
    Heartbeat: ultra-processed foods and atrial fibrillation risk.
    Heart. 2023;109:1651-1653.

  18. FERKH A, Clark A, Thomas L
    Left atrial phasic function: physiology, clinical assessment and prognostic value.
    Heart. 2023;109:1661-1669.
    PubMed     Abstract available

  19. CHA MJ, Lee SA, Cho MS, Nam GB, et al
    Reduction of moderate to severe tricuspid regurgitation after catheter ablation for atrial fibrillation.
    Heart. 2023 Oct 25:heartjnl-2023-323244. doi: 10.1136/heartjnl-2023-323244.
    PubMed     Abstract available

  20. TEIGER E, Eschalier R, Amabile N, Rioufol G, et al
    Left atrial appendage closure in very elderly patients in the French National Registry.
    Heart. 2023 Oct 9:heartjnl-2023-322871. doi: 10.1136/heartjnl-2023-322871.
    PubMed     Abstract available

    September 2023
  21. LOPEZ-LIZARRAGA MA, Sanchez-Amaya DJ, Godinez-Cordova LB
    Paradoxical worsening of an arrhythmia due to antiarrhythmics.
    Heart. 2023;109:1515-1576.

  22. AKERSTROM F, Hutter J, Charitakis E, Tabrizi F, et al
    Association between catheter ablation of atrial fibrillation and mortality or stroke.
    Heart. 2023 Sep 1:heartjnl-2023-322883. doi: 10.1136/heartjnl-2023-322883.
    PubMed     Abstract available

    August 2023
  23. THAKUR A, Kumar S
    Palpitations in a young man after heavy work.
    Heart. 2023;109:1356-1418.

    Sex differences in cardiac sarcoidosis.
    Heart. 2023;109:1346-1347.

  25. ISO T, Maeda D, Matsue Y, Dotare T, et al
    Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis.
    Heart. 2023;109:1387-1393.
    PubMed     Abstract available

    Shortening time to defibrillation in shockable cardiac arrest matters: how do we do it?
    Heart. 2023;109:1344-1345.

  27. PONNUSAMY SS, Syed T, Vijayaraman P
    Pacing induced cardiomyopathy: recognition and management.
    Heart. 2023;109:1407-1415.
    PubMed     Abstract available

  28. DZESHKA MS, Shantsila A, Shantsila E, Lip GYH, et al
    Better blood pressure control in patients with atrial fibrillation: overcoming barriers to improve outcomes.
    Heart. 2023 Aug 17:heartjnl-2023-323028. doi: 10.1136/heartjnl-2023-323028.

    July 2023
  29. ANDRADE JG, Deyell MW, Bennett R, Macle L, et al
    Assessment and management of asymptomatic atrial fibrillation.
    Heart. 2023 Jul 28:heartjnl-2023-322428. doi: 10.1136/heartjnl-2023-322428.
    PubMed     Abstract available

  30. ANTIPEROVITCH P, Skanes A, Klein G, Tang A, et al
    Approach to a patient with asymptomatic pre-excitation.
    Heart. 2023;109:1254-1259.

  31. SAU A, Pastika L, Ng FS
    Atrial fibrillation phenotypes: the route to personalised care?
    Heart. 2023 Jul 24:heartjnl-2023-322812. doi: 10.1136/heartjnl-2023-322812.

  32. LAMBIASE PD, Maclean E
    Review of the National Institute for Health and Care Excellence guidelines on the management of atrial and ventricular arrhythmias.
    Heart. 2023 Jul 24:heartjnl-2022-322122. doi: 10.1136/heartjnl-2022-322122.
    PubMed     Abstract available

  33. HALL R, Raju H, Nalliah C
    Association of diet with atrial fibrillation: villain or sidekick.
    Heart. 2023 Jul 21:heartjnl-2023-322897. doi: 10.1136/heartjnl-2023-322897.

  34. TRIVEDI R, Marschner S, Shaw T, Min H, et al
    Factors influencing blood pressure control in patients with atrial fibrillation and hypertension in Australian primary care.
    Heart. 2023 Jul 20:heartjnl-2023-322602. doi: 10.1136/heartjnl-2023-322602.
    PubMed     Abstract available

  35. BEGGS SAS, Wright GA, Gardner RS
    Primary prevention implantable cardioverter defibrillators for patients with heart failure.
    Heart. 2023 Jul 18:heartjnl-2022-321728. doi: 10.1136/heartjnl-2022-321728.

  36. TU SJ, Gallagher C, Elliott AD, Bradbury KE, et al
    Associations of dietary patterns, ultra-processed food and nutrient intake with incident atrial fibrillation.
    Heart. 2023 Jul 17:heartjnl-2023-322412. doi: 10.1136/heartjnl-2023-322412.
    PubMed     Abstract available

  37. AFOKE J, Camacho E, Bagameri G
    Recurrent ventricular arrhythmia after aortic root replacement and mitral valve repair.
    Heart. 2023;109:1145-1192.

  38. KOLDENHOF T, Van Gelder IC, Crijns HJ, Rienstra M, et al
    Rate control in atrial fibrillation, calcium channel blockers versus beta-blockers.
    Heart. 2023 Jul 11:heartjnl-2023-322635. doi: 10.1136/heartjnl-2023-322635.
    PubMed     Abstract available

  39. AL-AIDAROUS S, Protonotarios A, Elliott PM, Lambiase PD, et al
    Management of arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2023 Jul 11:heartjnl-2023-322612. doi: 10.1136/heartjnl-2023-322612.
    PubMed     Abstract available

    June 2023
  40. OTTO CM
    Heartbeat: prediction of atrial fibrillation risk.
    Heart. 2023;109:1045-1047.

  41. KHAN I, Atoot A
    Patient with altered mental status.
    Heart. 2023;109:1063-1122.

  42. CAI H, Chen G, Hu W, Jiang C, et al
    Anticoagulant in atrial fibrillation patients with prior intracranial haemorrhage: a meta-analysis.
    Heart. 2023 Jun 15:heartjnl-2023-322492. doi: 10.1136/heartjnl-2023-322492.
    PubMed     Abstract available

  43. BANCHS J, Lech T
    Cardiovascular phenotypes and incident cardiovascular events in people with previous cancer.
    Heart. 2023;109:974-976.

  44. BEVAN G, Nazer B
    Exercise and arrhythmogenic cardiomyopathy: all things in moderation.
    Heart. 2023;109:972-973.

  45. RAMOS-MAQUEDA J, Migueles JH, Molina-Jimenez M, Ruiz-Gonzalez D, et al
    Lifestyle physical activity and rapid-rate non-sustained ventricular tachycardia in arrhythmogenic cardiomyopathy.
    Heart. 2023;109:992-999.
    PubMed     Abstract available

  46. SAITO Y, Omae Y, Nagashima K, Miyauchi K, et al
    Phenotyping of atrial fibrillation with cluster analysis and external validation.
    Heart. 2023 Jun 1:heartjnl-2023-322447. doi: 10.1136/heartjnl-2023-322447.
    PubMed     Abstract available

    May 2023
  47. BHATIA RT, Malhotra A, MacLachlan H, Gati S, et al
    Prevalence and diagnostic significance of de-novo 12-lead ECG changes after COVID-19 infection in elite soccer players.
    Heart. 2023;109:936-943.
    PubMed     Abstract available

    April 2023
  48. HATIPOGLU S, Gardezi SKM, Azzu A, Baksi J, et al
    Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
    Heart. 2023;109:748-755.
    PubMed     Abstract available

  49. CHOI YJ, Kim HK, Hwang IC, Park CS, et al
    Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
    Heart. 2023;109:771-778.
    PubMed     Abstract available

  50. RAISI-ESTABRAGH Z, Cooper J, McCracken C, Crosbie EJ, et al
    Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer.
    Heart. 2023 Apr 18:heartjnl-2022-321888. doi: 10.1136/heartjnl-2022-321888.
    PubMed     Abstract available

  51. KARAM N, Spaulding C
    Interventional management of out-of-hospital cardiac arrest.
    Heart. 2023;109:719-722.

  52. PINTO-FILHO MM, Paixao GM, Gomes PR, Soares CPM, et al
    Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study.
    Heart. 2023;109:668-673.
    PubMed     Abstract available

  53. DIEDERICHSEN SZ, Svennberg E
    Novel path: FINDing the way forward in screening for atrial fibrillation.
    Heart. 2023 Apr 5:heartjnl-2023-322395. doi: 10.1136/heartjnl-2023-322395.

  54. FLORIA M, Tanase DM
    Bradyarrhythmias in patients with atrial fibrillation.
    Heart. 2023 Apr 3:heartjnl-2023-322498. doi: 10.1136/heartjnl-2023-322498.

    March 2023
  55. MULLER SA, Te Riele ASJM
    Implantable cardioverter-defibrillator shocks during long-term follow-up in arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2023 Mar 28:heartjnl-2022-322138. doi: 10.1136/heartjnl-2022-322138.

  56. MARON MS, Rowin E, Spirito P, Maron BJ, et al
    Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
    Heart. 2023;109:589-594.
    PubMed     Abstract available

  57. AHN HJ, Lee SR, Choi EK, Lee SW, et al
    Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA(2)DS(2)-VASc scores.
    Heart. 2023 Mar 24:heartjnl-2022-322143. doi: 10.1136/heartjnl-2022-322143.
    PubMed     Abstract available

  58. FRAUSING MHJP, Van De Lande ME, Maass AH, Nguyen BO, et al
    Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation.
    Heart. 2023 Mar 22:heartjnl-2022-322253. doi: 10.1136/heartjnl-2022-322253.
    PubMed     Abstract available

  59. MOLITOR N, Hofer D, Cimen T, Gasperetti A, et al
    Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2023 Mar 16:heartjnl-2022-321739. doi: 10.1136/heartjnl-2022-321739.
    PubMed     Abstract available

  60. FINK T, Sciacca V, Sommer P
    Catheter ablation of atrial fibrillation after percutaneous left atrial appendage closure: friend or foe?
    Heart. 2023 Mar 1:heartjnl-2023-322374. doi: 10.1136/heartjnl-2023-322374.

    February 2023
    Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death.
    Heart. 2023;109:434-441.
    PubMed     Abstract available

  62. BORSCHEL CS, Ortega-Alonso A, Havulinna AS, Jousilahti P, et al
    Inflammatory proteomics profiling for prediction of incident atrial fibrillation.
    Heart. 2023 Feb 17:heartjnl-2022-321959. doi: 10.1136/heartjnl-2022-321959.
    PubMed     Abstract available

  63. NADARAJAH R, Wu J, Hogg D, Raveendra K, et al
    Prediction of short-term atrial fibrillation risk using primary care electronic health records.
    Heart. 2023 Feb 9:heartjnl-2022-322076. doi: 10.1136/heartjnl-2022-322076.
    PubMed     Abstract available

  64. CHEN JJ, Chiu FC, Chang SN, Cheng HL, et al
    Impact of pre-existing left atrial appendage occluder on catheter ablation of atrial fibrillation.
    Heart. 2023 Feb 7:heartjnl-2022-321934. doi: 10.1136/heartjnl-2022-321934.
    PubMed     Abstract available

  65. KIM J, Kim D, Jang E, Kim D, et al
    Associations of high-normal blood pressure and impaired fasting glucose with atrial fibrillation.
    Heart. 2023 Feb 7:heartjnl-2022-322094. doi: 10.1136/heartjnl-2022-322094.
    PubMed     Abstract available

    January 2023
  66. OTTO CM
    Heartbeat: prevention of atrial fibrillation progression.
    Heart. 2023;109:159-161.

  67. JOY M, Williams J, Emanuel S, Kar D, et al
    Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014-2019).
    Heart. 2023;109:195-201.
    PubMed     Abstract available

  68. LINZ D, Schnabel RB
    Gut microbiota-derived metabolites in atrial fibrillation: risk markers or modifiable risk factors?
    Heart. 2023 Jan 2:heartjnl-2022-321806. doi: 10.1136/heartjnl-2022-321806.

    When will we learn? Differential outcomes in women following catheter ablation of atrial fibrillation.
    Heart. 2023 Jan 2:heartjnl-2022-322092. doi: 10.1136/heartjnl-2022-322092.

  70. LUCIANI M, Muller D, Vanetta C, Diteepeng T, et al
    Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation.
    Heart. 2023 Jan 2:heartjnl-2022-321300. doi: 10.1136/heartjnl-2022-321300.
    PubMed     Abstract available

    December 2022
  71. ANDERSON RH, Garbi M, Zugwitz D, Petersen SE, et al
    Anatomy of the mitral valve relative to controversies concerning the so-called annular disjunction.
    Heart. 2022 Dec 30:heartjnl-2022-322043. doi: 10.1136/heartjnl-2022-322043.
    PubMed     Abstract available

  72. PELLEGRINI CN, Buzkova P, Oesterle A, Heckbert SR, et al
    Dysregulated carbohydrate and lipid metabolism and risk of atrial fibrillation in advanced old age.
    Heart. 2022 Dec 22:heartjnl-2022-321633. doi: 10.1136/heartjnl-2022-321633.
    PubMed     Abstract available

  73. ARPS K, Piccini JP
    Women, men and the safety gap after catheter ablation of atrial fibrillation.
    Heart. 2022 Dec 22:heartjnl-2022-321632. doi: 10.1136/heartjnl-2022-321632.

  74. LOPEZ-LIZARRAGA MA, Ezquerra-Osorio A, Cueva-Parra A
    Woman with alternating QRS in the emergency department: what is happening?
    Heart. 2022;109:95-158.

  75. BULARGA A, Newby DE, Chapman AR
    Not to be sneezed at: cardiovascular disease after COVID-19 infection.
    Heart. 2022;109:84-85.

  76. SCARSINI R, Pighi M, Mainardi A, Portolan L, et al
    Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis.
    Heart. 2022 Dec 13:heartjnl-2022-321907. doi: 10.1136/heartjnl-2022-321907.
    PubMed     Abstract available

    November 2022
  77. WILKINSON C, Rockwood K
    Frailty assessment in the management of cardiovascular disease.
    Heart. 2022;108:1991-1995.

  78. GUPTA D, Ding WY, Calvert P, Williams E, et al
    Cryoballoon Pulmonary Vein Isolation as First-Line Treatment for Typical Atrial Flutter.
    Heart. 2022 Nov 17. pii: heartjnl-2022-321729. doi: 10.1136/heartjnl-2022-321729
    PubMed     Abstract available

  79. WEBER C, Hung J, Hickling S, Li I, et al
    Emergent readmission and long-term mortality risk after incident atrial fibrillation hospitalisation.
    Heart. 2022 Nov 16. pii: heartjnl-2022-321560. doi: 10.1136/heartjnl-2022-321560
    PubMed     Abstract available

  80. WALDMANN V, Khairy P
    Atrial fibrillation in Ebstein anomaly: weathering the storm.
    Heart. 2022 Nov 15. pii: heartjnl-2022-321876. doi: 10.1136/heartjnl-2022-321876

  81. MARTIN DE MIGUEL I, Madhavan M, Miranda WR, Connolly HM, et al
    Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.
    Heart. 2022 Nov 11. pii: heartjnl-2022-321493. doi: 10.1136/heartjnl-2022-321493
    PubMed     Abstract available

  82. BURSI F, Lee AP
    Strain and mitral regurgitation: is atrial functional mitral regurgitation a ventricular disease?
    Heart. 2022 Nov 11. pii: heartjnl-2022-321945. doi: 10.1136/heartjnl-2022-321945

  83. KITAI T, Nabeta T, Naruse Y, Taniguchi T, et al
    Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis.
    Heart. 2022;108:1887-1894.
    PubMed     Abstract available

  84. AEBERSOLD H, Serra-Burriel M, Foster-Wittassek F, Moschovitis G, et al
    Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort.
    Heart. 2022 Nov 4. pii: heartjnl-2022-321520. doi: 10.1136/heartjnl-2022-321520.
    PubMed     Abstract available

    October 2022
  85. CASO V, de Groot JR, Sanmartin Fernandez M, Segura T, et al
    Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2022 Oct 31. pii: heartjnl-2022-321114. doi: 10.1136/heartjnl-2022-321114
    PubMed     Abstract available

  86. LANE DJ, Grunau B, Kudenchuk P, Dorian P, et al
    Bayesian analysis of amiodarone or lidocaine versus placebo for out-of-hospital cardiac arrest.
    Heart. 2022;108:1777-1783.
    PubMed     Abstract available

  87. MEUCCI MC, Stassen J, Tomsic A, Palmen M, et al
    Prognostic impact of left ventricular global longitudinal strain in atrial mitral regurgitation.
    Heart. 2022 Oct 21. pii: heartjnl-2022-321698. doi: 10.1136/heartjnl-2022-321698
    PubMed     Abstract available

  88. LYNGBAKKEN MN, Ronningen PS, Solberg MG, Berge T, et al
    Prediction of incident atrial fibrillation with cardiac biomarkers and left atrial volumes.
    Heart. 2022 Oct 19. pii: heartjnl-2022-321608. doi: 10.1136/heartjnl-2022-321608
    PubMed     Abstract available

  89. RAMLAKHAN KP, Kauling RM, Schenkelaars N, Segers D, et al
    Supraventricular arrhythmia in pregnancy.
    Heart. 2022;108:1674-1681.
    PubMed     Abstract available

    September 2022
  90. HENDRIKS JM, Elliott AD, Middeldorp ME, Sanders P, et al
    Contributing factors to personalised medicine in atrial fibrillation.
    Heart. 2022 Sep 29. pii: heartjnl-2022-321553. doi: 10.1136/heartjnl-2022-321553

  91. LAWIN D, Lawrenz T, Marx K, Danielsmeier NB, et al
    Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Heart. 2022;108:1623-1628.
    PubMed     Abstract available

  92. MSZAR R, Friedman DJ, Ong E, Du C, et al
    Sex-based differences in atrial fibrillation ablation adverse events.
    Heart. 2022 Sep 14. pii: heartjnl-2022-321192. doi: 10.1136/heartjnl-2022-321192
    PubMed     Abstract available

  93. MARSCHNER S, von Huben A, Zaman S, Reynolds HR, et al
    Pregnancy-related cardiovascular conditions and outcomes in a United States Medicaid population.
    Heart. 2022;108:1524-1529.
    PubMed     Abstract available

    August 2022
  94. VAN DER VELDEN RMJ, Pluymaekers NAHA, Dudink EAMP, Luermans JGLM, et al
    Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation.
    Heart. 2022 Aug 29. pii: heartjnl-2022-321346. doi: 10.1136/heartjnl-2022-321346
    PubMed     Abstract available

  95. SANCHEZ-QUINTANA D, Anderson RH, Tretter JT, Cabrera JA, et al
    Anatomy of the conduction tissues 100 years on: what have we learned?
    Heart. 2022;108:1430-1437.
    PubMed     Abstract available

    July 2022
  96. PARALE C, Velayutham R, Anantharaj A
    Tachycardia in a young man: does pulse oximetry give a clue?
    Heart. 2022;108:1266-1330.

  97. NGUYEN BO, Weberndorfer V, Crijns HJ, Geelhoed B, et al
    Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation.
    Heart. 2022 Jul 20. pii: heartjnl-2022-321027. doi: 10.1136/heartjnl-2022-321027
    PubMed     Abstract available

  98. VILALTA V, Cediel G, Mohammadi S, Lopez H, et al
    New-onset persistent left bundle branch block following sutureless aortic valve replacement.
    Heart. 2022 Jul 16. pii: heartjnl-2022-321191. doi: 10.1136/heartjnl-2022-321191
    PubMed     Abstract available

  99. KANY S, Cardoso VR, Bravo L, Williams JA, et al
    Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Heart. 2022 Jul 14. pii: heartjnl-2022-321196. doi: 10.1136/heartjnl-2022-321196
    PubMed     Abstract available

  100. KIM HJ, Chang DH, Kim SO, Kim JK, et al
    Left atrial appendage preservation versus closure during surgical ablation of atrial fibrillation.
    Heart. 2022 Jul 13. pii: heartjnl-2022-320939. doi: 10.1136/heartjnl-2022-320939
    PubMed     Abstract available

    June 2022
  101. MARROQUIN L, Tirado-Conte G, Pracon R, Streb W, et al
    Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.
    Heart. 2022;108:1098-1106.
    PubMed     Abstract available

  102. AVILA P, Calvo D, Tamargo M, Uribarri A, et al
    Association of age with clinical features and ablation outcomes of paroxysmal supraventricular tachycardias.
    Heart. 2022;108:1107-1113.
    PubMed     Abstract available

  103. TAN HL, Remme CA
    Sudden cardiac death: recognising hidden risk among women versus men.
    Heart. 2022;108:992-993.

    May 2022
    Management of cardiac arrest in the cardiac catheterisation laboratory: guidelines tailored to place and occasion.
    Heart. 2022;108:907-908.

  105. OTTO CM
    Heartbeat: can cardiogenetics reduce adverse events due to catecholaminergic polymorphic ventricular tachycardia?
    Heart. 2022;108:816-818.

  106. POSTEMA PG, van der Werf C
    Catecholaminergic polymorphic ventricular tachycardia: differences in inheritance and implications for patients, families and future studies.
    Heart. 2022;108:820-821.

  107. SHIMAMOTO K, Ohno S, Kato K, Takayama K, et al
    Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1.
    Heart. 2022;108:840-847.
    PubMed     Abstract available

  108. MARSMAN EMJ, Postema PG, Remme CA
    Brugada syndrome: update and future perspectives.
    Heart. 2022;108:668-675.
    PubMed     Abstract available

  109. HAYDOCK P, Camm AJ
    History and evolution of pacing and devices.
    Heart. 2022;108:794-799.
    PubMed     Abstract available

    April 2022
  110. ROSEBOOM E, Maass AH
    Inherited and modifiable factors need to be identified in young patients with atrioventricular block.
    Heart. 2022 Apr 5. pii: heartjnl-2022-320841. doi: 10.1136/heartjnl-2022-320841.

  111. KOMEN J, Pottegard A, Hjemdahl P, Mantel-Teeuwisse AK, et al
    Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.
    Heart. 2022;108:613-618.
    PubMed     Abstract available

  112. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    PubMed     Abstract available

  113. HOLT A, Blanche P, Zareini B, Rasmussen PV, et al
    Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants.
    Heart. 2022;108:626-632.
    PubMed     Abstract available

  114. HIGUCHI K, Bhargava M
    Management of premature ventricular complexes.
    Heart. 2022;108:565-572.

    March 2022
  115. PARK YJ, Park JW, Yu HT, Kim TH, et al
    Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs.
    Heart. 2022 Mar 24. pii: heartjnl-2021-320601. doi: 10.1136/heartjnl-2021-320601
    PubMed     Abstract available

  116. RAATIKAINEN P, Lassila R
    COVID-19: another reason for anticoagulation in patients with atrial fibrillation.
    Heart. 2022 Mar 21. pii: heartjnl-2022-320845. doi: 10.1136/heartjnl-2022-320845

  117. GILL S, Bunting KV, Sartini C, Cardoso VR, et al
    Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis.
    Heart. 2022 Mar 11. pii: heartjnl-2021-320417. doi: 10.1136/heartjnl-2021-320417
    PubMed     Abstract available

  118. HANDY A, Banerjee A, Wood AM, Dale C, et al
    Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
    Heart. 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325
    PubMed     Abstract available

  119. DYSSEKILDE JR, Christiansen MK, Johansen JB, Nielsen JC, et al
    Familial risk of atrioventricular block in first-degree relatives.
    Heart. 2022 Mar 4. pii: heartjnl-2021-320411. doi: 10.1136/heartjnl-2021-320411.
    PubMed     Abstract available

  120. FRANKE KB, Mahajan R
    Cardiac oxidative stress: a potential tool for risk stratification in cardiac sarcoidosis.
    Heart. 2022;108:410-411.

  121. YOSHITOMI R, Kobayashi S, Yano Y, Nakashima Y, et al
    Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
    Heart. 2022;108:429-437.
    PubMed     Abstract available

    February 2022
  122. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
    Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
    Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
    PubMed     Abstract available

  123. OTTO CM
    Heartbeat: bleeding risk in atrial fibrillation patients on non-vitamin K oral anticoagulant medications.
    Heart. 2022;108:243-245.

  124. GUPTA A, Arora GK, Isser HS
    An elderly woman with recurrent syncope.
    Heart. 2022;108:257-324.

  125. MORRONE D, De Caterina R
    Bleeding risk score: limits and practicability.
    Heart. 2022;108:246-248.

    January 2022
  126. TUTAREL O, Baris L, Budts W, Gamal Abd-El Aziz M, et al
    Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC).
    Heart. 2022;108:117-123.
    PubMed     Abstract available

  127. VITALE G, Ditaranto R, Graziani F, Tanini I, et al
    Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy.
    Heart. 2022;108:54-60.
    PubMed     Abstract available

    December 2021
  128. OTTO CM
    Heartbeat: lower risk of dementia with a direct oral anticoagulatant, compared to a vitamin K antagonist, for patients with atrial fibrillation.
    Heart. 2021;107:1847-1849.

  129. DING WY, Mahida S
    Wide complex tachycardia: differentiating ventricular tachycardia from supraventricular tachycardia.
    Heart. 2021;107:1995-2003.

    November 2021
  130. OTTO CM
    Heartbeat: ECG approaches to early detection of atrial fibrillation.
    Heart. 2021;107:1765-1767.

    October 2021
  131. HIMELFARB JD, Shulman H, Olesovsky CJ, Rumman RK, et al
    Atrial fibrillation following transcatheter atrial septal defect closure: a systematic review and meta-analysis.
    Heart. 2021 Oct 21. pii: heartjnl-2021-319794. doi: 10.1136/heartjnl-2021-319794
    PubMed     Abstract available

  132. DEYELL MW, Hawkins NM
    Odd couple: premature ventricular contractions and heart failure.
    Heart. 2021 Oct 19. pii: heartjnl-2021-319986. doi: 10.1136/heartjnl-2021-319986

  133. CADOGAN SL, Powell E, Wing K, Wong AY, et al
    Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319672. doi: 10.1136/heartjnl-2021-319672
    PubMed     Abstract available

  134. CHUA W
    Clearing the cognitive cloud: direct oral anticoagulants or vitamin K antagonists for reducing dementia risk in patients with atrial fibrillation?
    Heart. 2021 Oct 13. pii: heartjnl-2021-320138. doi: 10.1136/heartjnl-2021-320138

  135. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    PubMed     Abstract available

  136. ZAMAN J, Agarwal S
    Management of ventricular tachycardia storm.
    Heart. 2021;107:1671-1677.

    September 2021
  137. BARNETT-GRINESS O, Stein N, Kotler A, Saliba W, et al
    Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants.
    Heart. 2021 Sep 21. pii: heartjnl-2021-319702. doi: 10.1136/heartjnl-2021-319702
    PubMed     Abstract available

  138. KASHOU A, Noseworthy P
    Predicting incident atrial fibrillation in sinus rhythm: more than just trusting the 'black box'.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319385. doi: 10.1136/heartjnl-2021-319385.

  139. LIMPITIKUL WB, Dewland TA, Vittinghoff E, Soliman E, et al
    Premature ventricular complexes and development of heart failure in a community-based population.
    Heart. 2021 Sep 7. pii: heartjnl-2021-319473. doi: 10.1136/heartjnl-2021-319473.
    PubMed     Abstract available

  140. NASER JA, Pislaru S, Stan MN, Lin G, et al
    Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease.
    Heart. 2021 Sep 6. pii: heartjnl-2021-319752. doi: 10.1136/heartjnl-2021-319752.
    PubMed     Abstract available

    August 2021
  141. BLAAUW Y, Mulder B, Rienstra M
    Is catheter ablation of atrial fibrillation as first-line treatment ready for prime time?
    Heart. 2021 Aug 12. pii: heartjnl-2021-319832. doi: 10.1136/heartjnl-2021-319832

  142. KANY S, Schnabel R
    Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation.
    Heart. 2021 Aug 12. pii: heartjnl-2021-319830. doi: 10.1136/heartjnl-2021-319830

  143. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    PubMed     Abstract available

  144. TOOLEY JE, Perez MV
    Role of digital health in detection and management of atrial fibrillation.
    Heart. 2021 Aug 3. pii: heartjnl-2020-318262. doi: 10.1136/heartjnl-2020-318262.
    PubMed     Abstract available

  145. OTTO CM
    Heartbeat: improved quality of life and reduced healthcare utilisation after catheter ablation in patients with drug-resistant paroxysmal atrial fibrillation.
    Heart. 2021;107:1271-1273.

    July 2021
  146. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    PubMed     Abstract available

  147. IMBERTI JF, Ding WY, Kotalczyk A, Zhang J, et al
    Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319496. doi: 10.1136/heartjnl-2021-319496
    PubMed     Abstract available

  148. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    PubMed     Abstract available

    June 2021
  149. CHEN TH, Chu YC, Ou SM, Tarng DC, et al
    Associations of atrial fibrillation with renal function decline in patients with chronic kidney disease.
    Heart. 2021 Jun 30. pii: heartjnl-2021-319297. doi: 10.1136/heartjnl-2021-319297
    PubMed     Abstract available

  150. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    PubMed     Abstract available

  151. SANZ-GARCIA A, Cecconi A, Vera A, Camarasaltas JM, et al
    Electrocardiographic biomarkers to predict atrial fibrillation in sinus rhythm electrocardiograms.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319120. doi: 10.1136/heartjnl-2021-319120.
    PubMed     Abstract available

  152. MINNERS J, Jander N
    Consecutive, index and representative beats: obtaining reliable information despite an irregular heart rhythm.
    Heart. 2021;107:862-863.

  153. BRIGNOLE M, Rivasi G
    New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope.
    Heart. 2021;107:864-873.
    PubMed     Abstract available

  154. PARKER WA, Storey RF
    Antithrombotic therapy for patients with chronic coronary syndromes.
    Heart. 2021;107:925-933.

    May 2021
  155. WILDE AAM, Amin AS, Postema PG
    Diagnosis, management and therapeutic strategies for congenital long QT syndrome.
    Heart. 2021 May 26. pii: heartjnl-2020-318259. doi: 10.1136/heartjnl-2020-318259
    PubMed     Abstract available

  156. KAWAJI T, Ogawa H, Hamatani Y, Kato M, et al
    Association of inverted T wave during atrial fibrillation rhythm with subsequent cardiac events.
    Heart. 2021 May 26. pii: heartjnl-2021-319199. doi: 10.1136/heartjnl-2021-319199
    PubMed     Abstract available

  157. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
    Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
    PubMed     Abstract available

  158. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
    Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
    Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
    PubMed     Abstract available

  159. ELVAN A
    It's all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation.
    Heart. 2021 May 20. pii: heartjnl-2021-319382. doi: 10.1136/heartjnl-2021-319382

  160. BOSMAN LP, Te Riele ASJM
    Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
    Heart. 2021 May 14. pii: heartjnl-2021-319113. doi: 10.1136/heartjnl-2021-319113
    PubMed     Abstract available

  161. CHOI Y, Lee Y, Kim SH, Kim S, et al
    Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
    Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
    PubMed     Abstract available

  162. GUPTA D, Ding WY
    Contemporary management of persistent atrial fibrillation.
    Heart. 2021 May 14. pii: heartjnl-2020-317422. doi: 10.1136/heartjnl-2020-317422

  163. CHUA W, Fabritz L
    Heart failure in patients with atrial fibrillation: why it matters now more than ever.
    Heart. 2021 May 13. pii: heartjnl-2021-319145. doi: 10.1136/heartjnl-2021-319145

  164. RUTHERFORD OW, Jonasson C, Ghanima W, Soderdahl F, et al
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation.
    Heart. 2021 May 11. pii: heartjnl-2020-318753. doi: 10.1136/heartjnl-2020-318753
    PubMed     Abstract available

  165. GUPTA D, Vijgen J, Potter T, Scherr D, et al
    Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.
    Heart. 2021 May 5. pii: heartjnl-2020-318676. doi: 10.1136/heartjnl-2020-318676.
    PubMed     Abstract available

  166. JOLOBE O
    Next frontier is inclusion of high-grade carotid artery stenosis in the CHA2DS2 Vasc score.
    Heart. 2021;107:767.

    Stroke risk in rheumatic heart disease.
    Heart. 2021;107:694-696.

  168. FAN P, Zhang Y, Lu YT, Yang KQ, et al
    Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
    Heart. 2021;107:836-841.
    PubMed     Abstract available

    April 2021
  169. SANTOS IS, Bensenor IM
    Cardiovascular health and atrial fibrillation.
    Heart. 2021 Apr 15. pii: heartjnl-2021-319253. doi: 10.1136/heartjnl-2021-319253

  170. LEE JH, Yang PS, Yu HT, Kim TH, et al
    Association of cardiovascular health and incident atrial fibrillation in elderly population.
    Heart. 2021 Apr 2. pii: heartjnl-2020-318858. doi: 10.1136/heartjnl-2020-318858.
    PubMed     Abstract available

  171. YEO C, Wang Y, Tan VH
    Wide complex tachycardia captured on smartwatch.
    Heart. 2021;107:626-684.

  172. GEURINK K, Holmes D, Ezekowitz MD, Pieper K, et al
    Patterns of oral anticoagulation use with cardioversion in clinical practice.
    Heart. 2021;107:642-649.
    PubMed     Abstract available

  173. SPARROW R, Sanjoy S, Choi YH, Elgendy IY, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure.
    Heart. 2021 Apr 1. pii: heartjnl-2020-318650. doi: 10.1136/heartjnl-2020-318650.
    PubMed     Abstract available

    February 2021
    Biomarkers for detection of a thrombus in the left atrial appendage: the search for the grail?
    Heart. 2021;107:176-177.

    January 2021
  175. SINGH T, Newby DE
    Is the fear of disease worse than the disease itself?
    Heart. 2021;107:91-92.

    October 2020
  176. MULDER BA, Rienstra M, Blaauw Y
    Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction.
    Heart. 2020 Oct 19. pii: heartjnl-2020-317491. doi: 10.1136/heartjnl-2020-317491
    PubMed     Abstract available

    September 2020
  177. IHSAN J, Khand A, Adlan AM
    Ventricular storm following late presentation acute myocardial infarction.
    Heart. 2020;106:1399-1448.

    May 2020
  178. KIM WK, Kim HJ, Kim JB, Jung SH, et al
    Exclusion versus preservation of the left atrial appendage in rheumatic mitral valve surgery.
    Heart. 2020 May 6. pii: heartjnl-2019-316387. doi: 10.1136/heartjnl-2019-316387.
    PubMed     Abstract available

    January 2020
  179. TAN TC, Nunes MCP, Handschumacher M, Pontes-Neto O, et al
    Left atrial cross-sectional area is a novel measure of atrial shape associated with cardioembolic strokes.
    Heart. 2020 Jan 24. pii: heartjnl-2019-315964. doi: 10.1136/heartjnl-2019-315964
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.